RVG TFA

• CAT Number: I040237
• Molecular Formula: C141H217N43O43S2.xC2HF3O2
• Molecular Weight: 3266.62 (free base)
• Purity: ≥95%

RVG TFA(CAT: I040237) is a synthetic peptide derived from the Rabies Virus Glycoprotein, known for its high-affinity binding to the α7 subunit of nicotinic acetylcholine receptors (nAchR) on neuronal cells. This targeting capability makes RVG TFA a powerful tool for delivering therapeutic or antigenic payloads across the blood-brain barrier and into the central nervous system. Notably, RVG has been shown to enhance the delivery of Mycobacterium tuberculosis antigens to antigen-presenting cells, supporting vaccine research and neuroimmunology studies. RVG TFA is ideal for applications involving targeted delivery, CNS immune modulation, and receptor-mediated transport.